PDE-5 ИНГИБИТОРЛАРИ(СИЛДЕНАФИЛ, ТАДАЛАФИЛ)НИ КЎЛЛАШ ЗАМОНАВИЙ ЮТУҚЛАРИ

Authors

  • Жолымбетов Исламбек Пазылбекович Республика ихтисослаштирилган акушерлик ва гинекология илмий-амалий тиббиёт маркази Тошкент, Ўзбекистон.

Abstract

Долзарблиги. Фетоплацентар етишмовчилик (ФПE) – йўлдошдаги морфофункционал ўзгаришлар ва органнинг функционал ҳолатини таъминлайдиган компенсатор-мослашув механизмларининг бузилиши натижасида юзага келадиган клиник синдром. Замонавий тиббиёт қанчалик ривожланмасин фетоплацентар етишмовчилик нафақат перинатал даврда, балки туғруқдан кейинги даврда ва бола ривожланишининг кейинги босқичларида ҳам болаларнинг юқори касалланиши ва улар ўлимининг асосий сабабларидан бири бўлиб қолмоқда.

References

ФОЙДАЛАНИЛГАН АДАБИЁТЛАР:

Зайналова Ситорамох Абдурофиевна. Особенности морфофункционального состояния фетоплацентарного комплекса при неблагоприятных экологических факторах. 2015г

Лазарева Г. А., Хурасева А. Б., Клычева О. И. Современный взгляд на проблему фетоплацентарной недостаточности. Актуальные проблемы медицины 2014г

Тапильская Н. И., Мельников К. Н., Кузнецова И. А., Глушаков. Р. И.. Плацентарная недостаточность и синдром задержки роста плода: этиология, профилактика, лечение doi: 10.33667/2078-5631-2020-4-6-10

A. Pels, L. C. Kenny, Z. Alfirevic, P. N. Baker, Peter von Dadelszen, C. Gluud, C. T. Kariya, B. W. Mol, A. T. Papageorghiou, A. G. van Wassenaer-Leemhuis, W. Ganzevoort, K. M. Groom and the international STRIDER Consortium. STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials. Pels et al. BMC Pregnancy and Childbirth (2017) 17:440. DOI 10.1186/s12884-017-1594-z

Felix Rafael De Bie, David Basurto, Sailesh Kumar, Jan Deprest and Francesca Maria Russo. Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations. Int. J. Environ. Res. Public Health 2022, 19, 11207. doi.org/10.3390/ijerph191811207

Jessica Turner, MRCOG1; Liam Dunn, PhD; William Tarnow-Mordi, MBChB; Christopher Flatley, PhD; Vicki Flenady, PhD; Sailesh Kumar, FRCOG, FRANZCOG, DPhil (Oxon) Safety and efficacy of sildenafil citrate to reduce operative birth for intrapartum fetal compromise at term: a phase 2 randomized controlled trial. American Journal of Obstetrics & Gynecology May 2020. doi.org/10.1016/j.ajog.2020.01.025

Makoto Tsuji, Shintaro Maki, Naosuke Enomoto, Kota Okamoto, Asa Kitamura, Shoichi Magawa, Sho Takakura, Masafumi Nii, Kayo Tanaka, Noriko Yodoya, Hiroaki Tanaka, Hirofumi Sawada, Eiji Kondo, Masahiro Hirayama and Tomoaki Ikeda. Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction. Medicina 2023, 59, 900. doi.org/10.3390/medicina59050900

Michi Kasai, Osamu Yasui, Kenji Nagao, Yuka Maegawa, Tomomi Kotani, Masayuki Endo, Ichiro Yasuhi, Shigeru Aoki, Yoichi Aoki, Yoshio Yoshida, Masahiko Nakata, Akihiko Sekizawa, Tomoaki Ikeda. Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial. Maki S, et al. BMJ Open 2022;12:e054925. doi:10.1136/bmjopen-2021-054925

Mohammed Maged, Alaa Wageh, Maher Shams, Abdlgawad Elmetwally. Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial. Taiwanese Journal of Obstetrics & Gynecology 57 (2018) 483e486. doi.org/10.1016/j.tjog.2018.06.002

Raquel Domingues da Silva Ferreira, Romulo Negrini, Wanderley Marques Bernardo, Ricardo Simões, Sebastião Piato. The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis. PLOS ONE 2019. doi.org/10.1371/journal.pone.0219732

Elsayed Elbadawy Mohammed, Osama Saed Alashkar, Tamer Mamdouh Abdeldayem* and Sarah Alhassan Mohammed. The use of low dose sildenafil citrate in cases of intrauterine growth restriction. Clin Obstet Gynecol Reprod Med, 2017. Volume 3(4): 1-5.

doi: 10.15761/COGRM.1000192

Liam Dunn, Vicki Flenady and Sailesh Kumar. Reducing the risk of fetal distress with sildenafil study (RIDSTRESS): a double blind randomised control trial. Dunn et al. Journal of Translational Medicine (2016). DOI 10.1186/s12967-016-0769-0

Liam Dunn, Ristan Greer, Vicki Flenady, Sailesh Kumar. Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes. Fetal Diagn Ther 2017;41:81–88. DOI: 10.1159/000453062

Downloads

Published

2023-09-12